These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 38331200)

  • 1. Unmasking the potential of secretory IgA and its pivotal role in protection from respiratory viruses.
    Sinha D; Yaugel-Novoa M; Waeckel L; Paul S; Longet S
    Antiviral Res; 2024 Mar; 223():105823. PubMed ID: 38331200
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oral Bacteria Combined with an Intranasal Vaccine Protect from Influenza A Virus and SARS-CoV-2 Infection.
    Nagai M; Moriyama M; Ichinohe T
    mBio; 2021 Aug; 12(4):e0159821. PubMed ID: 34399617
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vaccination and Omicron BA.1/BA.2 Convalescence Enhance Systemic but Not Mucosal Immunity against BA.4/5.
    Diem G; Jäger M; Dichtl S; Bauer A; Lass-Flörl C; Reindl M; Wilflingseder D; Posch W
    Microbiol Spectr; 2023 Jun; 11(3):e0516322. PubMed ID: 37098903
    [TBL] [Abstract][Full Text] [Related]  

  • 4. SARS-CoV-2 vaccination induces mucosal antibody responses in previously infected individuals.
    Sano K; Bhavsar D; Singh G; Floda D; Srivastava K; Gleason C; ; Carreño JM; Simon V; Krammer F
    Nat Commun; 2022 Sep; 13(1):5135. PubMed ID: 36050304
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Salivary anti-SARS-CoV-2 IgA as an accessible biomarker of mucosal immunity against COVID-19.
    Varadhachary A; Chatterjee D; Garza J; Garr RP; Foley C; Letkeman A; Dean J; Haug D; Breeze J; Traylor R; Malek A; Nath R; Linbeck L
    medRxiv; 2020 Aug; ():. PubMed ID: 32817976
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Salivary and serum IgA and IgG responses to SARS-CoV-2-spike protein following SARS-CoV-2 infection and after immunization with COVID-19 vaccines.
    Li D; Calderone R; Nsouli TM; Reznikov E; Bellanti JA
    Allergy Asthma Proc; 2022 Sep; 43(5):419-430. PubMed ID: 36065108
    [No Abstract]   [Full Text] [Related]  

  • 7. Intranasal vaccination induced cross-protective secretory IgA antibodies against SARS-CoV-2 variants with reducing the potential risk of lung eosinophilic immunopathology.
    Hemmi T; Ainai A; Hashiguchi T; Tobiume M; Kanno T; Iwata-Yoshikawa N; Iida S; Sato Y; Miyamoto S; Ueno A; Sano K; Saito S; Shiwa-Sudo N; Nagata N; Tamura K; Suzuki R; Hasegawa H; Suzuki T
    Vaccine; 2022 Sep; 40(41):5892-5903. PubMed ID: 36064667
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A Bacteriophage-Based, Highly Efficacious, Needle- and Adjuvant-Free, Mucosal COVID-19 Vaccine.
    Zhu J; Jain S; Sha J; Batra H; Ananthaswamy N; Kilgore PB; Hendrix EK; Hosakote YM; Wu X; Olano JP; Kayode A; Galindo CL; Banga S; Drelich A; Tat V; Tseng CK; Chopra AK; Rao VB
    mBio; 2022 Aug; 13(4):e0182222. PubMed ID: 35900097
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of Vaccination Against Influenza, Pertussis, and COVID-19 on Human Milk Antibodies: Current Evidence and Implications for Health Equity.
    Hunagund S; Golan Y; Asiodu IV; Prahl M; Gaw SL
    Front Immunol; 2022; 13():910383. PubMed ID: 35903100
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Towards broad-spectrum protection: the development and challenges of combined respiratory virus vaccines.
    Wang Y; Wei X; Liu Y; Li S; Pan W; Dai J; Yang Z
    Front Cell Infect Microbiol; 2024; 14():1412478. PubMed ID: 38903942
    [TBL] [Abstract][Full Text] [Related]  

  • 11. SARS-CoV-2 convalescence and hybrid immunity elicits mucosal immune responses.
    Puhach O; Bellon M; Adea K; Bekliz M; Hosszu-Fellous K; Sattonnet P; Hulo N; Kaiser L; Eckerle I; Meyer B
    EBioMedicine; 2023 Dec; 98():104893. PubMed ID: 38035462
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of SARS-CoV-2 spike-specific IgA and IgG in nasal secretions, saliva and serum.
    Bladh O; Aguilera K; Marking U; Kihlgren M; Greilert Norin N; Smed-Sörensen A; Sällberg Chen M; Klingström J; Blom K; Russell MW; Havervall S; Thålin C; Åberg M
    Front Immunol; 2024; 15():1346749. PubMed ID: 38558811
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Obesity Is Associated with an Impaired Baseline Repertoire of Anti-Influenza Virus Antibodies.
    Abd Alhadi M; Friedman LM; Karlsson EA; Cohen-Lavi L; Burkovitz A; Schultz-Cherry S; Noah TL; Weir SS; Shulman LM; Beck MA; Hertz T
    Microbiol Spectr; 2023 Jun; 11(3):e0001023. PubMed ID: 37098954
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Viral-vectored respiratory mucosal vaccine strategies.
    Jeyanathan M; Afkhami S; Kang A; Xing Z
    Curr Opin Immunol; 2023 Oct; 84():102370. PubMed ID: 37499279
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A Single Dose of BNT162b2 Messenger RNA Vaccine Induces Airway Immunity in Severe Acute Respiratory Syndrome Coronavirus 2 Naive and Recovered Coronavirus Disease 2019 Subjects.
    Martinuzzi E; Benzaquen J; Guerin O; Leroy S; Simon T; Ilie M; Hofman V; Allegra M; Tanga V; Michel E; Boutros J; Maniel C; Sicard A; Glaichenhaus N; Czerkinsky C; Blancou P; Hofman P; Marquette CH
    Clin Infect Dis; 2022 Dec; 75(12):2053-2059. PubMed ID: 35579991
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhalable hybrid nanovaccines with virus-biomimetic structure boost protective immune responses against SARS-CoV-2 variants.
    Wang S; Ding P; Shen L; Fan D; Cheng H; Huo J; Wei X; He H; Zhang G
    J Nanobiotechnology; 2024 Feb; 22(1):76. PubMed ID: 38414031
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A delayed resurgence of respiratory syncytial virus (RSV) during the COVID-19 pandemic: An unpredictable outbreak in a small proportion of children in the Southwest of Iran, April 2022.
    Mohebi L; Karami H; Mirsalehi N; Ardestani NH; Yavarian J; Mard-Soltani M; Mokhatri-Azad T; Salimi V
    J Med Virol; 2022 Dec; 94(12):5802-5807. PubMed ID: 35961780
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An ELISA-Based Method to Measure Mucosal Antibody Responses Against SARS-CoV-2 in Human Saliva.
    Bhavsar D; Sano K; Singh G; Krammer F
    Curr Protoc; 2024 Apr; 4(4):e1024. PubMed ID: 38578049
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of Three Multiplex Real-time Reverse Transcription PCR Assays for Simultaneous Detection of SARS-CoV-2, Influenza A/B, and Respiratory Syncytial Virus in Nasopharyngeal Swabs.
    Yun J; Park JH; Kim N; Roh EY; Shin S; Yoon JH; Kim TS; Park H
    J Korean Med Sci; 2021 Dec; 36(48):e328. PubMed ID: 34904407
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mucosal immunization with an adenoviral vector vaccine confers superior protection against RSV compared to natural immunity.
    Maier C; Fuchs J; Irrgang P; Wißing MH; Beyerlein J; Tenbusch M; Lapuente D
    Front Immunol; 2022; 13():920256. PubMed ID: 36003372
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.